On January 7, 2021 Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, reported that Michele Garufi, Chairman and Chief Executive Officer of Nicox, will present in a fireside chat at the H.C. Wainwright BioConnect Conference being held virtually on January 11-14, 2021 (Press release, NicOx, JAN 7, 2021, https://www.nicox.com/news-media/nicox-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference/ [SID1234573630]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A video webcast of Nicox’s presentation will be available on-demand from Monday January 11 at 6:00 a.m. EST for one week by clicking here and accessible on Nicox’s website (www.nicox.com) in the "Presentations & Events" section. The video webcast will be available for 90 days.